SCHEMBL18507798

SCHEMBL18507798

COP(=O)(OC)On1nnc2ccccc2c1=O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
HPGD P15428 2/20 0.49
TSHR P16473 2/20 0.49
MAPK1 P28482 2/20 0.49
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.49
LMNA P02545 1/20 0.49
CYP3A4 P08684 1/20 0.49
ALOX15 P16050 1/20 0.49
HSD17B10 Q99714 1/20 0.49
SMN1; SMN2 Q16637 4/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
HPSE Q9Y251 1/20 0.41
MAPK10 P53779 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17839910 0.91 ALDH1A1 (0.49) ALDH1A1HPGDTSHRMAPK1MAPT
SCHEMBL29394827 0.85 SMN1; SMN2 (0.49) ALDH1A1HPGDTSHRMAPK1MAPT
SCHEMBL76069 0.85 SMN1; SMN2 (0.49) ALDH1A1HPGDTSHRMAPK1MAPT
SCHEMBL1188683 0.83 SMN1; SMN2 (0.42) ALDH1A1HPGDTSHRMAPK1MAPT
SCHEMBL17391071 0.82 ALDH1A1 (0.48) ALDH1A1HPGDTSHRMAPK1MAPT
SCHEMBL1058740 0.81 ALDH1A1 (0.51) ALDH1A1HPGDTSHRMAPK1MAPT
SCHEMBL757021 0.81 ALDH1A1 (0.56) ALDH1A1HPGDTSHRMAPK1MAPT
SCHEMBL17973539 0.78 ALDH1A1 (0.48) ALDH1A1HPGDTSHRMAPK1MAPT
SCHEMBL30861605 0.76 MEN1 (0.52) ALDH1A1HPGDTSHRMAPK1MAPT
SCHEMBL22597948 0.75 POLB (0.43) ALDH1A1HPGDTSHRKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9572802-B2 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity THERAVANCE RESPIRATORY COMPANY LLC (US) 2017-02-21 US disclosed